Kaushal Mohit's Form 4 filing
Starling Oncology, Inc. (DFPH) · filed Apr 16, 2026
- Accession no.
- 0001079973-26-000499
- Filed
- Apr 16, 2026
- Trade date
- Apr 14-16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $335.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kaushal MohitCIK 0001683021 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price of $3.5017 was the volume weighted average selling price of all sales by the reporting person on April 14, 2026 within a one-dollar range. Actual prices ranged from $3.5000 to $3.5300. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price of $3.5005 was the volume weighted average selling price of all sales by the reporting person on April 16, 2026 within a one-dollar range. Actual prices ranged from $3.5000 to $3.5050. The reporting person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.